기업 프로필 · Healthcare

Progyny Inc

PGNY · 미국
국가 / 지역
USA
상장일
2019년 10월 25일
직원 수
835
웹사이트
www.progyny.com
Buffett Score
43/100
다소 약함
시가총액US$19.36억
매출 (TTM)US$13.11억
EBITDAUS$1.26억
순이익률6%
ROE16.24%
PER (TTM)27.42
선행 PER11.85
EPSUS$0.92
52주 범위US$16.10 – US$33.07
애널리스트 목표주가US$34.42
애널리스트 평가4.6 / 5

데이터 제공: EODHD, 보고 통화 기준 표시. 참고용일 뿐 투자 자문이 아닙니다.

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

연혁

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

업계 내 위치

준비 중이 섹션은 작성 중입니다. 곧 다시 확인해 주세요.

이 종목에 대한 리포트가 아직 해당 언어로 없습니다.